))
What's Up With Zuranolone for PPD?
Manage episode 374104820 series 3009595
Content provided by Anna Glezer, MD, Anna Glezer, and MD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Anna Glezer, MD, Anna Glezer, and MD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Zuranolone is a new FDA approved medication for postpartum depression, a condition affecting 20% of postpartum women. In this episode, we'll cover the science behind the medication - the mechanism of how it works - the data and research that led to the approval, and four different aspects that require additional information and study to figure out who is going to be the ideal patient for this new and exciting treatment tool.
To learn more about me and my reproductive & integrative psychiatry clinic helping patients across California, please visit - AnnaGlezerMD.com
To sign up for the Fellowship in Reproductive & Integrative Psychiatry, please visit: PsychiatryFellowship.com
Links: AJP Zuranolone for PPD Article: https://pubmed.ncbi.nlm.nih.gov/37491938/
91 episodes
Share
